Interpretation of Chinese Expert Consensus on Endocrine Therapy for Recurrent Endometrial Cancer(2024 Edition)
CHEN Yao
WANG Zengying
WANG Yumeng
XIA Bairong
Abstract：Endometrial cancer is one of the malignant tumors of the female reproductive system,and the survival rate of the patients with advanced and recurrent endometrial cancer was significantly decreased.Traditional systemic therapies include chemotherapy and endocrine therapy.Approximately 90％of endometrial cancers are hormone receptor-positive.For slow-progressing,hormone receptor-positive endometrial cancers,endocrine therapy is the preferred first-line systemic therapy option.The Gynecologic Oncology Group of Chinese Medical Doctor Association Obstetricians and Gynecologists Branch organized the compilation of Chinese Expert Consensus on Endocrine Therapy for Recurrent Endometrial Cancer(2024 Edition),providing evidence-based recommendations covering the clinical manifestations,diagnosis,and endocrine therapy of recurrent endometrial cancer.This consensus aims to standardize endocrine therapy practice for recurrent endometrial cancer in clinical settings.
Keywords：Recurrent endometrial cancerEndocrine therapyHormone receptorCombination therapyExpert consensusInterpretation
Publication Date：2025-05-30
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 491-495 )